Skip to main content

Table 3 Adverse effects observed in JDM cohort (n = 31)

From: Favorable outcomes with reduced steroid use in juvenile dermatomyositis

Fractures (n = 4)

Talus (n = 1)

Multiple thoracic vertebrae, T6-T10, T12 (n = 1)

Avulsion fracture of the 3rd finger (n = 1)

Distal tibia (following trauma) (n = 1)

Avascular necrosis (n = 2)

Knees bilaterally (n = 1)

Ankle bones (n = 1)

Infections (n = 8) a

RSV (n = 1)

Campylobacter (n = 1)

Oral thrush (n = 3)

Cellulitis (n = 1)

Pleural effusion (n = 1)

Impetigo (n = 1)

Vaginal candidiasis (n = 1)

Viral meningitis (n = 1)

Pneumonia (n = 1)

Streptococcal bacteremia (n = 1)

CMV reactivation (n = 1)

Herpes zoster (n = 2)

Growth (n = 2)

Short stature (n = 1)

Poor weight gain (n = 1)

  1. a3 patients had multiple infections